The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Genomic Analysis of Smoothened Inhibitor Resistance in Basal Cell Carcinoma
Open accessAbstract
SUMMARY Smoothened (SMO) inhibitors are under clinical investigation for the treatment of several cancers. Vismodegib is approved for the treatment of locally advanced and metastatic basal cell carcinoma (BCC). Most BCC patients experience significant clinical benefit on vismodegib, however, some develop resistance. Genomic analysis of tumor biopsies revealed vismodegib resistance is associated with Hedgehog (Hh) pathway reactivation, predominantly through mutation of the drug target SMO and to a lesser extent through concurrent copy number changes in SUFU and GLI2. SMO mutations either directly impaired drug binding or activated SMO to varying levels. Furthermore, we found evidence for intra-tumor heterogeneity, suggesting that a combination of therapies targeting components at multiple levels of the Hh pathway is required to overcome resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461
Mutational landscape and significance across 12 major cancer types
Kandoth, C., McLellan, M. D., Vandin, F., Ye, K., Niu, B., Lu, C., Xie, M., Zhang, Q., McMichael, J. F., Wyczalkowski, M. A., et al. (2013) · Nature · doi:10.1038/nature12634 · Cited by 4,419
Genomic instability — an evolving hallmark of cancer
Negrini, S., Gorgoulis, V. G., & Halazonetis, T. D. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2858 · Cited by 2,397
Mutations of the Human Homolog of Drosophila patched in the Nevoid Basal Cell Carcinoma Syndrome
Hahn, H., Wicking, C., Zaphiropoulos, P. G., Gailani, M. R., Shanley, S., Chidambaram, A., Vorechovsky, I., Holmberg, E., Unden, A. B., Gillies, S., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81268-4 · Cited by 2,022
Human Homolog of patched , a Candidate Gene for the Basal Cell Nevus Syndrome
Johnson, R. L., Rothman, A. L., Xie, J., Goodrich, L. V., Bare, J. W., Bonifas, J. M., Quinn, A. G., Myers, R. M., Cox, D. R., Epstein, E. H., et al. (1996) · Science · doi:10.1126/science.272.5268.1668 · Cited by 1,857
Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma
Sekulic, A., Migden, M. R., Oro, A. E., Dirix, L., Lewis, K. D., Hainsworth, J. D., Solomon, J. A., Yoo, S., Arron, S. T., Friedlander, P. A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113713 · Cited by 1,464
Self-citationThe Life History of 21 Breast Cancers
Nik-Zainal, S., Van Loo, P., Wedge, D. C., Alexandrov, L. B., Greenman, C. D., Lau, K. W., Raine, K., Jones, D., Marshall, J., Ramakrishna, M., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.023 · Cited by 1,443
Control of Neuronal Precursor Proliferation in the Cerebellum by Sonic Hedgehog
Wechsler-Reya, R. J., & Scott, M. P. (1999) · Neuron · doi:10.1016/s0896-6273(00)80682-0 · Cited by 1,341
Activating Smoothened mutations in sporadic basal-cell carcinoma
Xie, J., Murone, M., Luoh, S.-M., Ryan, A., Gu, Q., Zhang, C., Bonifas, J. M., Lam, C.-W., Hynes, M., Goddard, A., et al. (1998) · Nature · doi:10.1038/34201 · Cited by 1,334
Self-citationStructure-Function of the G Protein–Coupled Receptor Superfamily
Katritch, V., Cherezov, V., & Stevens, R. C. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-032112-135923 · Cited by 1,054
Genomic Analysis of Non- NF2 Meningiomas Reveals Mutations in TRAF7 , KLF4 , AKT1 , and SMO
Clark, V. E., Erson-Omay, E. Z., Serin, A., Yin, J., Cotney, J., Özduman, K., Avşar, T., Li, J., Murray, P. B., Henegariu, O., et al. (2013) · Science · doi:10.1126/science.1233009 · Cited by 912
Smoothened Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastoma
Yauch, R. L., Dijkgraaf, G. J. P., Alicke, B., Januario, T., Ahn, C. P., Holcomb, T., Pujara, K., Stinson, J., Callahan, C. A., Tang, T., et al. (2009) · Science · doi:10.1126/science.1179386 · Cited by 839
Self-citationMutations in SUFU predispose to medulloblastoma
Taylor, M. D., Liu, L., Raffel, C., Hui, C.-C., Mainprize, T. G., Zhang, X., Agatep, R., Chiappa, S., Gao, L., Lowrance, A., et al. (2002) · Nature Genetics · doi:10.1038/ng916 · Cited by 806
González-Pérez, A., & López-Bigas, N. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.03.004 · Cited by 765
Genome Sequencing of SHH Medulloblastoma Predicts Genotype-Related Response to Smoothened Inhibition
Kool, M., Jones, D. T. W., Jäger, N., Northcott, P. A., Pugh, T. J., Hovestadt, V., Piro, R. M., Esparza, L. A., Markant, S. L., Remke, M., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.02.004 · Cited by 762
Basal Cell Carcinomas in Mice Overexpressing Sonic Hedgehog
Oro, A. E., Higgins, K. M., Hu, Z., Bonifas, J. M., Epstein, E. H., & Scott, M. P. (1997) · Science · doi:10.1126/science.276.5313.817 · Cited by 710
Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations
Brastianos, P. K., Horowitz, P. M., Santagata, S., Jones, R. T., McKenna, A., Getz, G., Ligon, K. L., Palescandolo, E., Van Hummelen, P., Ducar, M. D., et al. (2013) · Nature Genetics · doi:10.1038/ng.2526 · Cited by 651
Buonamici, S., Williams, J., Morrissey, M., Wang, A., Guo, R., Vattay, A., Hsiao, K., Yuan, J., Green, J., Ospina, B., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001599 · Cited by 562
Unraveling the therapeutic potential of the Hedgehog pathway in cancer
Amakye, D., Jagani, Z., & Dorsch, M. (2013) · Nature Medicine · doi:10.1038/nm.3389 · Cited by 547
LoRusso, P. M., Rudin, C. M., Reddy, J. C., Tibes, R., Weiss, G. J., Borad, M. J., Hann, C. L., Brahmer, J. R., Chang, I., Darbonne, W. C., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2745 · Cited by 544
Self-citationSvärd, J., Henricson, K. H., Persson-Lek, M., Rozell, B., Lauth, M., Bergström, Å., Ericson, J., Toftgård, R., & Teglund, S. (2006) · Developmental Cell · doi:10.1016/j.devcel.2005.12.013 · Cited by 468
Structure of the human smoothened receptor bound to an antitumour agent
Wang, C., Wu, H., Katritch, V., Han, G. W., Huang, X.-P., Liu, W., Siu, F. Y., Roth, B. L., Cherezov, V., & Stevens, R. C. (2013) · Nature · doi:10.1038/nature12167 · Cited by 464
Inukai, M., Toyooka, S., Ito, S., Asano, H., Ichihara, S., Soh, J., Suehisa, H., Ouchida, M., Aoe, K., Aoe, M., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1951 · Cited by 452
REIFENBERGER, J., Wolter, M., Weber, R. G., Megahed, M., Ruzicka, T., Lichter, P., & Reifenberger, G. (1998) · PubMed · Cited by 426
Somatic mutations in the PTCH,SMOH,SUFUH and TP53 genes in sporadic basal cell carcinomas
Reifenberger, J., Wolter, M., Knobbe, C. B., Köhler, B., Schönicke, A., Scharwächter, C., Kumar, K., Blaschke, B., Ruzicka, T., & Reifenberger, G. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06353.x · Cited by 399
Identification of recurrent SMO and BRAF mutations in ameloblastomas
Sweeney, R. T., McClary, A. C., Myers, B. R., Biscocho, J., Neahring, L., Kwei, K. A., Qu, K., Gong, X., Ng, T., Jones, C. D., et al. (2014) · Nature Genetics · doi:10.1038/ng.2986 · Cited by 366
Dijkgraaf, G. J. P., Alicke, B., Weinmann, L., Januario, T., West, K., Modrusan, Z., Burdick, D., Goldsmith, R., Robarge, K., Sutherlin, D., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2876 · Cited by 363
Self-citationEpigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition
Tang, Y., Gholamin, S., Schubert, S., Willardson, M. I., Lee, A., Bandopadhayay, P., Bergthold, G., Masoud, S., Nguyen, B., Vue, N., et al. (2014) · Nature Medicine · doi:10.1038/nm.3613 · Cited by 314
Self-citationSmith, M. J., Beetz, C., Williams, S. G., Bhaskar, S. S., O’Sullivan, J., Anderson, B., Daly, S. B., Urquhart, J. E., Bholah, Z., Oudit, D., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.2569 · Cited by 300
Structural Instability of a Constitutively Active G Protein-coupled Receptor
Gether, U., Seifert, R., Ballesteros, J. A., Sanders-Bush, E., Weinstein, H., & Kobilka, B. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.5.2587 · Cited by 295
Mutagenic specificity of ultraviolet light
Miller, J. H. (1985) · Journal of Molecular Biology · doi:10.1016/0022-2836(85)90026-9 · Cited by 278
GLI activation by atypical protein kinase C ι/λ regulates the growth of basal cell carcinomas
Atwood, S. X., Li, M., Lee, A., Tang, J. Y., & Oro, A. E. (2013) · Nature · doi:10.1038/nature11889 · Cited by 237
Self-citationMutational Landscape of Basal Cell Carcinomas by Whole-Exome Sequencing
Jayaraman, S. S., Rayhan, D. J., Hazany, S., & Kolodney, M. S. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.276 · Cited by 221
Loss of suppressor-of-fused function promotes tumorigenesis
Lee, Y., Kawagoe, R., Sasai, K., Li, Y., Russell, H. R., Curran, T., & McKinnon, P. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210467 · Cited by 218
Oxysterol binding to the extracellular domain of Smoothened in Hedgehog signaling
Nedelcu, D., Liu, J., Xu, Y., Jao, C., & Salic, A. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1290 · Cited by 213
PICNIC: an algorithm to predict absolute allelic copy number variation with microarray cancer data
Greenman, C. D., Bignell, G., Butler, A., Edkins, S., Hinton, J., Beare, D., Swamy, S., Santarius, T., Chen, L., Widaa, S., et al. (2010) · Biostatistics · doi:10.1093/biostatistics/kxp045 · Cited by 196
Stone, D. M., Murone, M., Luoh, S.-M., Ye, W., Armanini, M. P., Gurney, A., Phillips, H., Brush, J., Goddard, A., Sauvage, F. J. D., et al. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.23.4437 · Cited by 191
Identification of a SUFU germline mutation in a family with Gorlin syndrome
Pastorino, L., Ghiorzo, P., Nasti, S., Battistuzzi, L., Cusano, R., Marzocchi, C., Garrè, M. L., Clementi, M., & Scarrà, G. B. (2009) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32944 · Cited by 187
Initial Assessment of Tumor Regrowth After Vismodegib in Advanced Basal Cell Carcinoma
Chang, A. L. S., & Oro, A. E. (2012) · Archives of Dermatology · doi:10.1001/archdermatol.2012.2354 · Cited by 176
Mechanisms of Acquired Resistance to Targeted Cancer Therapies
Lackner, M. R., Wilson, T. R., & Settleman, J. (2012) · Future Oncology · doi:10.2217/fon.12.86 · Cited by 164
Smoothened (SMO) receptor mutations dictate resistance to vismodegib in basal cell carcinoma
Pricl, S., Cortelazzi, B., Col, V. D., Marson, D., Laurini, E., Fermeglia, M., Licitra, L. F., Pilotti, S., Bossi, P., & Perrone, F. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.09.003 · Cited by 155
Sasai, K., Romer, J. T., Lee, Y., Finkelstein, D., Fuller, C. E., McKinnon, P. J., & Curran, T. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4505 · Cited by 154
Wong, H. H., Alicke, B., West, K. A., Pacheco, P., La, H., Januario, T., Yauch, R. L., de Sauvage, F. J., & Gould, S. E. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0975 · Cited by 118
Self-citationLong, J., Li, B., Rodríguez‐Blanco, J., Pastori, C., Volmar, C., Wahlestedt, C., Capobianco, A. J., Bai, F., Pei, X., Ayad, N. G., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.595348 · Cited by 112
Kijima, C., Miyashita, T., Suzuki, M., Oka, H., & Fujii, K. (2012) · Familial Cancer · doi:10.1007/s10689-012-9548-0 · Cited by 83
Brinkhuizen, T., Reinders, M. G. H. C., van Geel, M., Hendriksen, A. J. L., Paulussen, A. D. C., Winnepenninckx, V. J. L., Keymeulen, K., Soetekouw, P. M. M. B., Steensel, M. A. M. V., & Mosterd, K. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2014.08.001 · Cited by 75
PTEN Loss Mitigates the Response of Medulloblastoma to Hedgehog Pathway Inhibition
Metcalfe, C., Alicke, B., Crow, A., Lamoureux, M., Dijkgraaf, G. J. P., Peale, F. V., Jr., Gould, S. E., & de Sauvage, F. J. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1222 · Cited by 65
Self-citationThe Evolution of Melanoma Resistance Reveals Therapeutic Opportunities
Thakur, M. D., & Stuart, D. D. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1633 · Cited by 59
Cited by
A distinct role for Lgr5+ stem cells in primary and metastatic colon cancer
de Sousa e Melo, F., Kurtova, A. V., Harnoss, J. M., Kljavin, N., Hoeck, J. D., Hung, J., Anderson, J. E., Storm, E. E., Modrusan, Z., Koeppen, H., et al. (2017) · Nature · doi:10.1038/nature21713 · Cited by 788
Self-citationThe great escape: tumour cell plasticity in resistance to targeted therapy
Boumahdi, S., & de Sauvage, F. J. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0044-1 · Cited by 761
Self-citationClara, J. A., Monge, C., Yang, Y., & Takebe, N. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0293-2 · Cited by 752
Amide Bond Bioisosteres: Strategies, Synthesis, and Successes
Kumari, S., Carmona, A. V., Tiwari, A. K., & Trippier, P. C. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00530 · Cited by 654
Peris, K., Fargnoli, M. C., Garbe, C., Kaufmann, R., Bastholt, L., Seguin, N. B., Bataille, V., Marmol, V. D., Dummer, R., Harwood, C. A., et al. (2019) · European Journal of Cancer · doi:10.1016/j.ejca.2019.06.003 · Cited by 599
Metadata
- Authors
- Sharpe, H. J., Pau, G., Dijkgraaf, G. J., Basset-Seguin, N., Modrusan, Z., Januario, T., Tsui, V., Durham, A. B., Dlugosz, A. A., Haverty, P. M., Bourgon, R., Tang, J. Y., Sarin, K. Y., Dirix, L., Fisher, D. C., Rudin, C. M., Sofen, H., Migden, M. R., Yauch, R. L., & de Sauvage, F. J.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2015-03
- Volume
- 27
- Issue
- 3
- Pages
- 327-341
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W1970915933
- Cited by
- 382
- References
- 48
- FWCI
- 17.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.